参考文献/References:
[1] Nather A, Bee CS, Huak CY, et al.Epidemiology of diabetic foot problems and predictive factors for limb loss[J]. J Diabetes Complications, 2008, 22(2):77-82.
[/br][2] 王丽君, 杨宏伟, 张幽幽, 等. 降钙素原在判断糖尿病足感染程度及预后中的价值[J].中华医院感染学杂志, 2014, 24(13):3378-3380.
[/br][3] Lavery LA, Armstrong DG, Wunderlich RP, et al. Risk factors for foot infections in individuals with diabetes[J].Diabetes Care, 2006, 29(6):1288-1293.
[/br][4] Akinci B, Yener S, Yesil S, et al. Acute phase reactants predict the risk of amputation in diabetic foot infection[J]. J Am Podiatr Med Assoc, 2011, 101(1):1-6.
[/br][5] Li X, Xiao T, Wang Y, et al. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital[J]. Diabetes Res Clin Pract, 2011, 93(1): 26-30.
[/br][6] Bloos F, Reinhart K. Rapid diagnosis of sepsis[J].Virulence, 2014, 5(1): 154-160.
[/br][7] Jonaidi Jafari N, Safaee Firouzabadi M, Izadi M, et al. Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers?[J].Int J Endocrinol Metab, 2014, 12(1): e13376.
[/br][8] Uzun G, Solmazgul E, Curuksulu H, et al. Procalcitonin as a diagnostic aid in diabetic foot infections[J].Tohoku J Exp Med, 2007, 213(4):305-312.
[/br][9] Saeed K, Ahmad N, Dryden M. The value of procalcitonin measurement in localized skin and skin structure infection, diabetic foot infections, septic arthritis and osteomyelitis[J].Expert Rev Mol Diagn, 2014, 14(1):47-54.
[/br][10] 张静,何红,张晓义,等. 糖尿病足患者发生截肢的危险因素[J]. 中国老年学杂志, 2014, 33(10):2829-2831.
[/br][11] Moura Neto A, Zantut-Wittmann DE, Fernandes TD, et al. Risk factors for ulceration and amputation in diabetic foot: study in a cohort of 496 patients[J]. Endocrine, 2013, 44(1): 119-124.
[/br][12] Michail M, Jude E, Liaskos C, et al. The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis[J].Int J Low Extrem Wounds,2013,12(2):94-99.
[/br][13] Mutluogˇlu M, Uzun G, Ipciogˇlu OM, et al. Can procalcitonin predict bone infection in people with diabetes with infected foot ulcers? A pilot study[J]. Diabetes Res Clin Pract, 2011, 94(1):53-56.
相似文献/References:
[1]李冬梅.高压氧治疗糖尿病足的疗效研究[J].国际内分泌代谢杂志,2014,(05):356.[doi:10.3760/cma.j.issn.1673-4157.2014.05.020]
Li Dongmei..Therapeutic effects of hyperbaric oxygen on patients with diabetic foot[J].International Journal of Endocrinology and Metabolism,2014,(06):356.[doi:10.3760/cma.j.issn.1673-4157.2014.05.020]
[2]张如意 张桦 王娇 孙嘉 陈容平 杨锐 冉建民 陈宏.超重或肥胖2型糖尿病患者糖尿病足的
患病率及相关危险因素分析[J].国际内分泌代谢杂志,2015,(06):365.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.002]
Zhang Ruyi*,Zhang Hua,Wang Jiao,et al.Prevalence and risk factors for diabetic foot in overweight or obese type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(06):365.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.002]
[3]樊立娜 李鹏辉 王芳 王祯 张雪晴 耿杨.糖尿病足患者血清同型半胱氨酸
及胱抑素C水平变化的研究[J].国际内分泌代谢杂志,2015,(06):374.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.004]
Fan Lina,Li Penghui,Wang Fang,et al.Serum level of homocysteine and cystatin C in patients with diabetic foot[J].International Journal of Endocrinology and Metabolism,2015,(06):374.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.004]
[4]李津凯,阚世廉,张秀军,等.前列地尔联合胰激肽原酶治疗早期
糖尿病足的疗效观察[J].国际内分泌代谢杂志,2016,36(02):121.[doi:10.3760/cma.j.issn.1673-4157.2016.02.011]
Li Jinkai*,Kan Shilian,Zhang Xiujun,et al.Curative effect of alprostadil combined with kallidinogenase on early diabetic foot[J].International Journal of Endocrinology and Metabolism,2016,36(06):121.[doi:10.3760/cma.j.issn.1673-4157.2016.02.011]
[5]许颖,孙玉芝,张朝晖,等.CXC趋化因子配体16与糖尿病足的
相关性探讨[J].国际内分泌代谢杂志,2016,36(04):230.[doi:10.3760/cma.j.issn.1673-4157.2016.04.05]
Xu Ying*,Sun Yuzhi,Zhang Zhaohui,et al.The correlation between CXC chemokine ligand 16 and diabetic foot[J].International Journal of Endocrinology and Metabolism,2016,36(06):230.[doi:10.3760/cma.j.issn.1673-4157.2016.04.05]
[6]裴翔 欧阳茹 陈铅琴.2型糖尿病患者血清胆红素水平
与糖尿病足的相关性[J].国际内分泌代谢杂志,2020,40(02):81.[doi:10.3760/cma.j.issn.1673-4157.2020.02.003]
Pei Xiang,Ouyang Ru,Chen Qianqin.Correlation between serum bilirubin level and diabetic foot in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2020,40(06):81.[doi:10.3760/cma.j.issn.1673-4157.2020.02.003]